Home LiteratureArticle Details
PMID: 1825650 Published · ppublish English Journal Article

Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression.

Japanese journal of cancer research : Gann ·Vol. 82 ·No. 1 ·1991-01-00 ·Pages 118-26

Muro M, Naomoto Y, Orita K

Abstract

We have studied the mechanism of the synergistic effect of the combination of tumor necrosis factor-alpha (TNF-alpha) and interferon-alpha (IFN-alpha) on cell cycle progression using two-parameter flow cytometry in vitro and an immunohistochemical staining method in vivo. The cells used were human colon cancer cell line RPMI 4788 in vitro and in vivo, and human breast cancer cell line MX-1 and human renal cancer cell line NAMKO-1 in vivo. In the in vitro experiment, the cell cycle progressed normally as time elapsed in the control group. However, in the group treated with TNF-alpha and IFN-alpha in combination (combination group), it appeared that the transition from the S phase to the G2/M phase was blocked, and the cells that accumulated in the S phase died. In the in vivo experiment with male nude mice of a CD-1 genetic background, the antitumor effect on all three kinds of cancer cells was significantly greater in the combination group than in the control group. The cell labeling index on staining with bromodeoxyuridine in the combination group became markedly larger and the mitotic index smaller than in the other groups. From these results, it was concluded that in the combination group, both in vitro and in vivo, tumor cells markedly accumulated in the S phase and their progression from the S phase to the G2/M phase in the cell cycle was inhibited.

MeSH Terms
Animals Bromodeoxyuridine Cell Cycle/drug effects Colonic Neoplasms/drug therapy,pathology Drug Synergism Interferon Type I/pharmacology Male Mice Mice, Nude Mitotic Index Propidium Specific Pathogen-Free Organisms Tumor Cells, Cultured/pathology Tumor Necrosis Factor-alpha/pharmacology
Chemicals
Interferon Type I Tumor Necrosis Factor-alpha Propidium Bromodeoxyuridine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Muro M
First Department of Surgery, Okayama University Medical School.
Naomoto Y
Orita K
References (37)
37 references, click to expand
  1. Chemotherapy of human tumor xenografts in genetically athymic mice.
    Ann Clin Lab Sci. 1978 Jan-Feb;8(1):50-6 PMID: 623430
  2. An interleukin 1 like factor stimulates bone resorption in vitro.
    Nature. 1983 Nov 24-30;306(5941):378-80 PMID: 6606132
  3. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
    J Exp Med. 1985 Dec 1;162(6):2163-8 PMID: 2999289
  4. Recombinant human tumor necrosis factor--II. Antitumor effect on murine and human tumors transplanted in mice.
    Int J Immunopharmacol. 1986;8(3):357-68 PMID: 3525434
  5. Simultaneous production of natural human tumor necrosis factor-alpha, -beta and interferon-alpha from BALL-1 cells stimulated by HVJ.
    Lymphokine Res. 1988 Summer;7(2):175-85 PMID: 2841543
  6. The analysis and interpretation of DNA distributions measured by flow cytometry.
    Cytometry. 1982 Nov;3(3):188-95 PMID: 6184208
  7. The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin.
    J Immunol. 1984 Sep;133(3):1083-6 PMID: 6430995
  8. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
    J Immunol. 1985 Dec;135(6):3972-7 PMID: 2999236
  9. Recombinant human tumor necrosis factor--I. Cytotoxic activity in vitro.
    Int J Immunopharmacol. 1986;8(3):347-55 PMID: 3525433
  10. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2474-7 PMID: 6264478
  11. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.
    Nature. 1985 Aug 8-14;316(6028):552-4 PMID: 2993897
  12. Novel experimental models of human cancer metastasis in nude mice: lung metastasis, intraabdominal carcinomatosis with ascites, and liver metastasis.
    J Cancer Res Clin Oncol. 1987;113(6):544-9 PMID: 3680363
  13. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.
    J Exp Med. 1986 Mar 1;163(3):632-43 PMID: 3512757
  14. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.
    Nature. 1985 Dec 19-1986 Jan 1;318(6047):665-7 PMID: 3001529
  15. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
    Cancer Res. 1989 Mar 15;49(6):1408-14 PMID: 2784349
  16. Lymphokines and monokines in anti-cancer therapy.
    Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:587-95 PMID: 3107882
  17. The expression of human tumor necrosis factor in E. coli.
    Nucleic Acids Symp Ser. 1986;(17):131-4 PMID: 3031624
  18. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1433-50 PMID: 3486936
  19. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
    J Immunol. 1986 Apr 1;136(7):2445-50 PMID: 3005411
  20. Antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha in combination against human cancer transplanted into nude mice.
    Acta Med Okayama. 1989 Aug;43(4):211-21 PMID: 2801185
  21. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.
    J Immunol. 1985 Dec;135(6):3969-71 PMID: 2999235
  22. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.
    Cancer Res. 1986 Aug;46(8):3990-3 PMID: 2425938
  23. Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon.
    Proc Natl Acad Sci U S A. 1980 Mar;77(3):1471-5 PMID: 6154934
  24. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
  25. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
    Proc Natl Acad Sci U S A. 1983 Sep;80(17):5397-401 PMID: 6193516
  26. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
    J Immunol. 1986 Apr 1;136(7):2441-4 PMID: 3005410
  27. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Nature. 1986 Apr 17-23;320(6063):584-8 PMID: 3010124
  28. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
    J Immunol. 1985 Sep;135(3):2069-73 PMID: 3926894
  29. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.
    Nature. 1986 Feb 6-12;319(6053):516-8 PMID: 3511389
  30. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
    Science. 1985 Nov 22;230(4728):943-5 PMID: 3933111
  31. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.
    Proc Natl Acad Sci U S A. 1982 Feb;79(3):912-6 PMID: 7038689
  32. Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity.
    Int J Cancer. 1988 Feb 15;41(2):243-7 PMID: 3338873
  33. GROWTH OF HUMAN TUMOR CELLS IN VITRO AND IN VIVO.
    Cancer. 1964 Jan;17:11-20 PMID: 14102064
  34. Cell cycle-specific effects of tumor necrosis factor.
    Cancer Res. 1984 Jan;44(1):83-90 PMID: 6690064
  35. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Cancer Res. 1987 Jul 15;47(14):3707-11 PMID: 3594435
  36. Synergism between human tumor necrosis factor and human interferon-alpha: effects on cells in culture.
    Acta Med Okayama. 1987 Aug;41(4):155-60 PMID: 3661240
  37. In vitro synergistic effects of natural human tumor necrosis factor and natural human interferon-alpha.
    Jpn J Cancer Res. 1987 Jan;78(1):87-92 PMID: 3102443
Article Info
Journal
Japanese journal of cancer research : Gann
Abbr.
Jpn J Cancer Res
ISSN
0910-5050
Published
1991-01-00
Pages
118-26
Language
English
Region
Japan
NLM ID
8509412
PMCID
PMC5918212
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com